Cargando…

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results

IMPORTANCE: Magnetic resonance imaging (MRI) and potential MRI-guided biopsy enable enhanced identification of clinically significant prostate cancer. Despite proven efficacy, MRI and potential MRI-guided biopsy remain costly, and there is limited evidence regarding the cost-effectiveness of this ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Hyunkyung, Kim, Jin, Gandhe, Aishwarya, Nelson, Brianna, Hu, Jim C., Gulani, Vikas, Margolis, Daniel, Schackman, Bruce R., Jalali, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687655/ https://www.ncbi.nlm.nih.gov/pubmed/38019516 http://dx.doi.org/10.1001/jamanetworkopen.2023.44856

Ejemplares similares

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study
por: Hao, Shuang, et al.
Publicado: (2022)

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study
por: Boesen, Lars, et al.
Publicado: (2018)

Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
por: Cheng, Li-Jen, et al.
Publicado: (2021)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

IDEAL Stage 2a experience with in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy
por: Tzeng, Michael, et al.
Publicado: (2019)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

The Clinical Value of Performing an MRI before Prostate Biopsy
por: Choi, Myung Sun, et al.
Publicado: (2011)

MRI-targeted prostate biopsy: the next step forward!
por: Cata, Emanuel Darius, et al.
Publicado: (2021)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer
por: Yin, Hongqing, et al.
Publicado: (2021)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies
por: Zhang, Li, et al.
Publicado: (2022)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Multiparametric MRI for Localized Prostate Cancer: Lesion Detection and Staging
por: Margolis, Daniel J. A.
Publicado: (2014)

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided
por: Rothwax, Jason T., et al.
Publicado: (2014)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

A critical comparison of techniques for MRI-targeted biopsy of the prostate
por: Giganti, Francesco, et al.
Publicado: (2017)

MRI-Targeted Prostate Biopsy: What Radiologists Should Know
por: Das, Chandan J, et al.
Publicado: (2020)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy
por: Pereira, Nalisson Marques, et al.
Publicado: (2023)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

Concordance of MRI-Guided Fusion and Systematic 12-Core Prostate Biopsy for the Detection of Prostate Cancer
por: Parsons, Matthew, et al.
Publicado: (2022)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
por: Abd Ali, Furat, et al.
Publicado: (2023)

Computational imaging reveals shape differences between normal and malignant prostates on MRI
por: Rusu, Mirabela, et al.
Publicado: (2017)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
por: Jahnen, Matthias, et al.
Publicado: (2023)

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011)

Multiparametric MRI-Targeted TRUS Prostate Biopsies Using Visual Registration
por: Puech, Philippe, et al.
Publicado: (2014)

Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
por: Connor, Martin J., et al.
Publicado: (2020)

Software-assisted US/MRI fusion-targeted biopsy for prostate cancer
por: Angileri, Salvatore Alessio, et al.
Publicado: (2020)

How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Park, Byung Kwan
Publicado: (2021)

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy
por: Kalalahti, Inari, et al.
Publicado: (2022)

Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions
por: Zhu, Alec, et al.
Publicado: (2023)

A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators
por: Patel, Hiten D., et al.
Publicado: (2022)

MRI in Prostate Cancer
por: Ghafoori, Mahyar, et al.
Publicado: (2013)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7luv4g00e39c4es7aq5fsoq218